David Shaw’s Cidara Therapeutics CDTX Stock Holding History

David Shaw’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,109	Closed	-$466K	–	4591
2025 Q4	$466K	Sell	2,109 -36,724	-95%	-$5.94M	﹤0.01%	3961
2025 Q3	$3.72M	Buy	+38,833	New	+$2.48M	﹤0.01%	2475

David Shaw's CDTX Position: Q1 2026 in Review

David Shaw sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 2,109 shares — an estimated $466K sold.

David Shaw first reported a position in CDTX in Q3 2025 and held it in 2 quarters. The position peaked at $3.72M in Q3 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

David Shaw reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
David Shaw sold 2,109 Cidara Therapeutics shares in Q1 2026, an estimated $466K.
David Shaw first reported a position in Cidara Therapeutics in Q3 2025 and held it in 2 quarters.
David Shaw's Cidara Therapeutics position peaked at $3.72M in Q3 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.